26May 2022
Navigated laser and aflibercept versus aflibercept monotherapy in treatment‐naïve branch retinal vein occlusion: A 12‐month randomized trial

Navigated laser and aflibercept versus aflibercept monotherapy in treatment‐naïve branch retinal vein occlusion: A 12‐month randomized trial

The study aimed to evaluate if a combination treatment of navigated central retinal laser and aflibercept lowered the treatment burden in these patients. The study evaluated 41 eyes of 41 patients with a mean age of 69.6 years. In treatment‐naïve BRVO patients, the addition of navigated central laser to aflibercept did not lower the treatment burden or affect functional or anatomical outcomes.

  • #ophthalmology

Like

Save

Share